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Summary
Objective: The European Union–funded E‐PILEPSY network (now continuing
within the European Reference Network for rare and complex epilepsies [Epi-
CARE]) aims to harmonize and optimize presurgical diagnostic procedures by
creating and implementing evidence‐based guidelines across Europe. The present
study evaluates the current evidence on the diagnostic accuracy of long‐term
video‐electroencephalographic monitoring (LTM) in identifying the epileptogenic
zone in epilepsy surgery candidates.
Methods: MEDLINE, Embase, CENTRAL, and ClinicalTrials.gov were searched
for relevant articles. First, we used random‐effects meta‐analytical models to cal-
culate pooled estimates of sensitivity and specificity with respect to postsurgical
seizure freedom. In a second phase, we analyzed individual patient data in an
exploratory fashion, assessing diagnostic accuracy within lesional and nonlesional
temporal lobe epilepsy (TLE) and extratemporal lobe epilepsy (ETLE) patients.
We also evaluated seizure freedom rate in the presence of “localizing” or “nonlo-
calizing” LTM within each group. The quality of evidence was assessed using the
QUADAS‐2 tool and the GRADE approach.
Results: Ninety‐four studies were eligible. Forty‐four were included in sensitivity
meta‐analysis and 34 in specificity meta‐analysis. Pooled sensitivity was 0.70 (95%
confidence interval [CI] = 0.60‐0.80) and specificity was 0.40 (95% CI = 0.27‐
0.54). Subgroup analysis was based on individual data of 534 patients (41% men).
In lesional TLE patients, sensitivity was 0.85 (95% CI = 0.81‐0.89) and specificity
was −0.19 (95% CI = 0.13‐0.28). In lesional ETLE patients, a sensitivity of 0.47
(95% CI = 0.36‐0.58) and specificity of 0.35 (95% CI = 0.21‐0.53) were observed.
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In lesional TLE, if LTM was localizing and concordant with resection site, the sei-
zure freedom rate was 247 of 333 (74%), whereas in lesional ETLE it was 34 of 56
(61%). The quality of evidence was assigned as “very low.”
Significance: Long‐term video‐electroencephalographic monitoring is associated
with moderate sensitivity and low specificity in identification of the epileptogenic
zone. Sensitivity is remarkably higher in lesional TLE compared to lesional
ETLE. Substantial heterogeneity across the studies indicates the need for
improved design and quality of reporting.
KEYWORD S
epilepsy surgery, seizure outcome, sensitivity, specificity, video-EEG
1 | INTRODUCTION
Epilepsy surgery has been proven to be a highly
effective treatment in carefully selected patients with
drug‐resistant focal epilepsies1–5 and is associated with a
significant proportion of seizure‐free patients, improved
quality of life, and reduced health care and societal
costs.6–11 However, epilepsy surgery remains largely
underutilized.12
In 2014, a European Union–funded pilot European Ref-
erence Network (E‐PILEPSY; http://www.ucl.ac.uk/www.e-
pilepsy.eu) of reference centers for refractory epilepsy and
epilepsy surgery was established with the aim of harmoniz-
ing and optimizing presurgical diagnostic procedures by
creating and implementing evidence‐based guidelines and
recommendations across Europe.
Video‐electroencephalographic (EEG) long‐term moni-
toring (LTM) is the centerpiece of the presurgical evalua-
tion.13–17 However, the diagnostic value of LTM in
defining the particular brain region that has to be removed
to make the patient seizure‐free (ie, the epileptogenic zone
[EZ]) is unclear. Here, we present a systematic review of
the current evidence for sensitivity and specificity of LTM
in defining the EZ.
2 | MATERIALS AND METHODS
A protocol for this review was developed in consultation
with the E‐PILEPSY expert panel and published on PROS-
PERO (CRD42016041938).18
The review addressed the following research question:
what is the diagnostic accuracy of noninvasive LTM in the
presurgical evaluation of patients with pharmacoresistant
epilepsy? The index test was LTM. The reference standard
was seizure freedom (yes/no), based on data from at least 1
year of follow‐up after surgery.
The results of this systematic review were reported in
accordance with the PRISMA statement (Table S1).19
2.1 | Sources of information
The comprehensive search strategies (Appendix S1)
were implemented in the bibliographic databases MEDLINE
(PubMed), Embase, CENTRAL, and ClinicalTrials.gov. The
searches were carried out in June 2015. The searches were
limited to human studies; no other restrictions were imposed.
2.2 | Eligibility criteria
We included all studies, irrespective of their design and
methodological quality if they (1) sought to assess the diag-
nostic accuracy of a presurgical noninvasive LTM or pro-
vided data sufficient for estimating sensitivity and specificity
Key Points
• The pooled sensitivity and specificity of LTM in
identification of the EZ in presurgical evaluation
of epilepsy were 70% and 40%, respectively
• In the subgroup of lesional TLE patients, sensi-
tivity was higher (85%) compared to the sensitiv-
ity (47%) observed in the lesional ETLE group
• In lesional TLE patients, the rate of seizure free-
dom was 74% when LTM was “localizing” and
concordant with the site of surgical resection
• A high risk of bias was observed in a consider-
able proportion of included studies; the quality
of evidence was assigned as “very low”
• There is a clear need for improvement in plan-
ning, conducting, and reporting of studies on
diagnostic utility of LTM
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of LTM, (2) included pharmacoresistant epilepsy patients
(definition as stated in the article) who underwent epilepsy
surgery (resective/palliative), and (3) reported postoperative
seizure outcome at a minimum of 1 year of follow‐up. Stud-
ies were excluded if they (1) were not published in English,
(2) were narrative reviews, or (3) were published only in
abstract form or as conference proceedings.
Patients had to fulfill the following criteria for inclusion
in the subgroup analysis at the individual level: (1) under-
went a presurgical noninvasive LTM, (2) had resective
(complete resection) epilepsy surgery, (3) were followed up
for at least 1 year after surgery, and (4) had detailed pre-
sentation of data on surgical intervention (eg, side, loca-
tion). Patients were excluded if they had (1) a generalized
epilepsy syndrome, (2) palliative epilepsy surgery, (3)
incomplete resection due to proximity/overlap with elo-
quent brain area of a presumed EZ (as stated in the article),
or (4) brain surgery not associated with epilepsy.
2.3 | Definitions
We applied the following definitions for the purpose of this
review (the rationales behind these definitions are provided
in Appendix S2):
• Long-term monitoring was defined as localizing when,
based on ictal electroclinical findings, it pointed to a sin-
gle focal brain area at a sublobar or lobar level, or to a
contiguous brain region if more than one adjacent lobes
were involved.
• The term electroclinical findings refers to lateralizing
and localizing ictal EEG findings in combination with
the seizure semiology being documented with the video-
EEG recordings.
• Long-term monitoring was defined as nonlocalizing
when, based on ictal electroclinical findings, it pointed
to more than one separate brain area (ie, independent
focus) or to the involvement of the entire brain, or was
noninformative.
• Localizing LTM result was classified as true positive (TP)
or false positive (FP) if, after resective surgery, the patient
achieved or failed to achieve seizure freedom, respec-
tively. Concordance between the site of LTM localization
and the site of surgical resection was required.
• Localizing LTM was classified as concordant with the
site of surgery if a brain area being localized by LTM
coincided with the resected EZ at the sublobar or lobar
level. Partial concordance at the sublobar level also qual-
ified as a concordant result. However, if the resected EZ
involved brain area that was not pointed out by LTM, it
was considered discordant.
• Nonlocalizing LTM result was defined as true negative
(TN) or false negative (FN) if, after resective surgery,
the patient failed to achieve or achieved seizure freedom,
respectively.
• Seizure freedom was defined as complete absence of sei-
zures (Engel class IA or International League Against
Epilepsy class Ia; if the study did not specify the sub-
class or the classification scale used, complete cessation
of seizures had to be reported) at a minimum of 1 year
of postoperative follow-up.
• Sensitivity was defined as the ability of a noninvasive
LTM to correctly localize the EZ in patients with local-
ization-related epilepsy who became seizure-free after
resective surgery. In other words, sensitivity was the pro-
portion of seizure-free patients who had localizing LTM
results concordant with the site of surgical resection.
• Specificity was the proportion of patients with nonlocal-
izing LTM results who failed to achieve seizure freedom
after resective surgery.
2.4 | Study selection
Titles and abstracts were screened initially, by pairs of 10
reviewers (T.K., G.Ku., J.H., G.Ka., M.L., J.D., A.R., C.N.,
F.E., F.B.). Full texts of selected articles were then evaluated
for eligibility against predefined criteria. Any disagreements
were resolved through discussion; a third reviewer was con-
sulted when consensus could not be reached.
2.5 | Data collection
Two independent reviewers (T.K., G.Ku.) conducted the
data extraction by using a Web‐based, standardized, piloted
data extraction form (Table S2). It was organized into six
domains that contained 121 items. Disagreements were
resolved through discussions. If consensus was not reached,
the judgment was referred to a third reviewer (F.B.).
2.6 | Assessment of study quality
Two independent reviewers (T.K., G.Ku.) assessed the
quality of individual studies in accordance with the QUA-
DAS‐2 tool,20 with disagreements resolved by consensus or
by consulting the third reviewer (F.B.). The items of a
quality appraisal tool were adapted and piloted to ensure
consistency of interpretation among the reviewers. Results
were summarized and presented for studies that contributed
to the individual level analysis only.
The quality of evidence across studies was assessed
using the GRADE methodology.21 Criteria suggested for
downgrading the quality of evidence were modified when
necessary. A list of all patient‐important outcomes was
generated and ranked according to their importance on
a 1‐9 scale. Quality appraisal was based on the
consensus of two independent reviewers (T.K., F.B).
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Summary of findings tables were generated for all
patient‐important outcomes that included a relevant num-
ber of patients.
2.7 | Synthesis of results
Data analysis was conducted in two phases.
2.7.1 | First phase: A study‐level analysis
Studies that provided sufficient data to create 2 × 2 contin-
gency tables were pooled in meta‐analysis. In case the vari-
ance estimates were equal to 0 (ie, if sensitivity/specificity
were 0 or 1), the rule “add two successes and two failures”
proposed by Agresti and Caffo22 was used. We set up two
univariate random‐effects meta‐analytical models, with sen-
sitivity and specificity as effect sizes, respectively. The
rationale behind selecting this method is provided in
Appendix S3.
2.7.2 | Second phase: Subgroup analysis at
individual patient level
Individual patient data were collected from the original arti-
cles when available. There were two reasons for this deci-
sion that had evolved over the course of the review: (1)
heterogeneity between studies or within study population
(eg, patients with different epilepsy types or syndromes)
and (2) evaluation of concordance between the site of
LTM localization and the site of surgical resection was
only possible at the individual level.
The analysis comprised two main steps. At first, we
assessed the diagnostic accuracy of noninvasive LTM in
different subgroups of patients. For this purpose, we classi-
fied the LTM findings for each patient as TP, TN, FP, or
FN, as shown in Table 1.This classification had to be based
on two variables: the result of a noninvasive LTM (index
test) and the postoperative seizure outcome (reference stan-
dard). However, in our study reference, standard was deter-
mined by surgical intervention, and therefore surgery must
have been considered when correlating the LTM result with
the postoperative seizure outcome. Whenever localizing
LTM was discordant with the site of surgery, the third vari-
able (concordance with surgery) had to be incorporated into
the analysis. This would make it impossible to use 2 × 2
table and hence to calculate the sensitivity and specificity.
Furthermore, when LTM was localizing and discordant
with the site of surgery and seizure remission was not
achieved we were unable to classify such cases. Therefore,
it was decided a priori to include in the 2 × 2 table only
those cases where LTM was either localizing and concor-
dant with the site of surgical resection, or was nonlocaliz-
ing. Hence, those cases where LTM was localizing but
discordant with the site of surgical resection (13 cases for
lesional temporal lobe epilepsy [TLE] and seven for
lesional extratemporal lobe epilepsy [ETLE]) were
excluded.
Considering the abovementioned reasons, the following
patient groups were included in the individual patient anal-
ysis:
• Patients with localizing LTM results who underwent sur-
gery (concordant with the brain area pointed out by non-
invasive LTM) and achieved seizure freedom.
• Patients with localizing LTM results who underwent sur-
gery (concordant with the brain area pointed out by non-
invasive LTM) but failed to enter surgical remission.
• Patients with nonlocalizing LTM results who underwent
surgery and achieved seizure freedom.
• Patients with nonlocalizing LTM results who underwent
surgery but failed to enter surgical remission.
Then, we calculated sensitivities and specificities for
lesional TLE and lesional ETLE patients separately.
Patients were allocated into the lesional or nonlesional epi-
lepsy group on the bases of magnetic resonance imaging
(MRI) and pathology findings. MRI‐negative patients with
a verifiable lesion on histology were attributed to the
lesional group. Additionally, we assessed the impact of cer-
tain pathologies on LTM accuracy in a graphical way. For
sensitivities, the number of TPs and FNs within each
pathological category were displayed in a bar plot. Graph-
ics for specificities were created analogously. To quantify
the findings from this descriptive analysis, we additionally
conducted simple logistic regression analyses for the data
of lesional TLE and ETLE subgroups, for each specific
pathology separately.
In the second part of the individual patient data analy-
sis, we evaluated how postoperative seizure outcome may
differ in the presence of localizing or nonlocalizing LTM
TABLE 1 A 2 × 2 contingency table illustrating correlation
between the LTM results, site of surgery, and seizure outcome
LTM
Site of
surgery
Seizure‐
free
Not
seizure‐free
Localizinga LTM Concordant
with the
resection siteb
TP FP
Nonlocalizingc LTM N/A FN TN
FN, false‐negative; FP, false‐positive; LTM, long-term video-electroencephalo-
graphic monitoring; N/A, not applicable; TN, true‐negative; TP, true‐positive.
aLTM findings localizing to a single focal brain area.
bSide and region of surgery is concordant with the LTM findings at the lobar/
sublobar level.
cLTM findings pointing to more than one separate brain area or to the entire
brain, or were noninformative.
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results. At first, for each subgroup, the LTM findings were
classified as either localizing or nonlocalizing. The localiz-
ing LTMs were further categorized into concordant and
discordant with respect to the site of surgical resection. We
then calculated the number of seizure‐free patients for each
category and summarized the results in a tabular form.
Finally, we compared the odds of being seizure‐free
between the patients with localizing and nonlocalizing
LTM results. Patients with localizing LTM discordant with
the resection site were excluded.
Statistical analyses were carried out using R version
3.3.2 (R Core Team 2016).23
3 | RESULTS
3.1 | Study selection
Ninety‐four studies were included in the review. Of these
94 studies, only 48 were eligible for meta‐analysis, and 40
for subgroup analysis (Table S3). The selection process
using the PRISMA flow diagram is shown in Figure 1.
3.2 | Study characteristics
Ninety‐four studies comprised 3541 patients. Eighty‐eight
of these studies were retrospective and six prospective,
mainly consisting of case series and case reports. Study
characteristics are summarized in Appendix S4 and Tables
S4.1-S4.5.
3.3 | Synthesis of results
3.3.1 | Phase 1: The study‐level meta‐analysis
We had to exclude several studies (n = 46) for the follow-
ing reasons: missing data (eg, studies in which neither TP
nor FN values were available, and hence the sensitivity
could not be calculated) and small “sample sizes” (eg, stud-
ies where the sum of the TP and FN values was equal to 0
or 1). Of the remaining 48 studies, we eventually included
44 studies (n = 1623 patients) in the sensitivity and 34
studies (n = 1391 patients) in the specificity meta‐analysis,
respectively.
The meta‐analyses yielded a sensitivity estimate of
0.70 (95% confidence interval [CI] = 0.60‐0.80) and a
specificity estimate of 0.40 (95% CI = 0.27‐0.54). Fig-
ures S1.1 and S1.2 show forest plots of sensitivity and
specificity, respectively. In both forest plots, the
between‐study variability seems to be quite large, which
is consistent with the highly significant results of the test
for heterogeneity (sensitivity: I² = 94.9%, 95% CI =
93.3‐97.3, P < 0.0001; specificity: I² = 92.6%, 95% CI =
86.6‐95.1, P < 0.0001).
We incorporated moderator variables in the meta‐analy-
tical models to explain this variability at least to some
extent. Among all variables included in the covariate analy-
sis, significant impact on sensitivity was shown with
increased proportion of patients with ETLE. Similar results
were seen with larger proportion of patients with concor-
dant MRI and LTM findings (Tables S5.1 and S5.2).
3.3.2 | Phase 2: Subgroup analysis
Individual patient data derived from 534 patients (156/384
[41%] men, 150/534 [28%] no data available) were pooled
into one single dataset and analyzed in an exploratory fash-
ion.
In the first step, the sensitivity and specificity estimates
of the LTM were assessed. This was performed for the
lesional TLE and lesional ETLE groups separately. In the
nonlesional TLE and nonlesional ETLE groups, the sample
size was too small to perform reliable statistical analysis
(Table S6). In lesional TLE patients, the pooled sensitivity
and specificity were 0.85 (95% CI = 0.81‐0.89) and 0.19
(95% CI = 0.13‐0.28), respectively, whereas in lesional
ETLE patients, we found a pooled sensitivity of 0.47 (95%
CI = 0.36‐0.58) and specificity of 0.35 (95% CI = 0.21‐
0.53).
In both lesional TLE and ETLE patients, we further
assessed the impact of certain etiologies (represented by
pathological findings) on the LTM accuracy in a graphical
way. The plots are depicted in Figures 2A, 2B, S2.1, and
S2.2. Regarding the distribution of pathologies, we can see
that in the lesional TLE group, hippocampal sclerosis is the
most common (219/406, 54%) finding on pathology. The
sensitivity and specificity of LTM with respect to hip-
pocampal sclerosis were 0.88 (95% CI = 0.82‐0.92) and
0.17 (95% CI = 0.09‐0.29), respectively. Details are pro-
vided in Appendix S5 and Table S7.
In a second step, we assessed the rate of seizure free-
dom with respect to localizing and nonlocalizing LTM cat-
egories in each subgroup. The results showed that in the
TLE group, the seizure freedom rate was 247 of 333 (74%)
if LTM was localizing and concordant with the site of a
resection. By contrast, in the nonlesional TLE group, the
seizure freedom rate with localizing and concordant LTM
was only four of 11 (36%; Table 2). We then compared the
odds of seizure freedom between two groups of patients
(LTM localizing and concordant with the resection site vs
nonlocalizing LTM) to see how the odds of being seizure‐
free differ in the presence/absence of localizing LTM. The
results showed that in the TLE group the odds of being sei-
zure‐free might be higher (odds ratio = 1.4, 95% CI = 0.8‐
2.5), when LTM is localizing and concordant with the
resection site compared to a nonlocalizing LTM. By con-
trast, in the lesional ETLE group, the contrary is true, with
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FIGURE 1 PRISMA flow diagram showing the selection process of the studies including in the review. *Reasons for excluding records or
full‐text articles were as follows. Title and abstracts screening stage: records were unrelated to the topic being reviewed (n = 498), abstracts were
not available (n = 2). Full text screening stage: no data given to assess the “localization ability” of noninvasive long‐term monitoring (LTM; n =
61), reference standard (postsurgical follow‐up [FU]) < 1 year (n = 3), not available in English (n = 15), full texts not available (n = 7), abstract
supplement (n = 75), data from single study was used in two papers (n = 1), no data given concerning epilepsy surgery (n = 1). Subgroup
analysis: studies did not provide individual patient data required to populate 2 × 2 contingency table (n = 44, including 2731 patients; in
addition, three more studies did not provide individual patient data for the subset of included patients [n = 109]; overall, individual patient data
were not provided for 2840 patients), patients with generalized epilepsy syndrome (n = 17), patients with palliative surgery (n = 15), patients
with incomplete resection (n = 18), patients in whom surgery was not performed (patient declined/lost to FU; n = 58), patients on ongoing
evaluation/waiting list (n = 2/n = 1), lost to FU (n = 2), FU < 1 year (n = 14), insufficient data regarding noninvasive LTM (n = 35), no LTM
performed (n = 2), surgery performed to treat acute symptomatic refractory status epilepticus (n = 1), bilateral surgery (n = 2). If there was more
than one reason for exclusion for the same patient, we counted it only once (eg, if there was incomplete resection of the epileptogenic zone and
FU < 1 year, only one of them was counted) in the above summary. For a more detailed description, see Table S2. ETLE, extratemporal lobe
epilepsy; TLE, temporal lobe epilepsy
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FIGURE 2 A, Sensitivity in the lesional temporal lobe epilepsy (TLE) group with respect to etiology represented by histopathological
findings. B, Specificity in the lesional TLE group with respect to etiology represented by histopathological findings. MCD, malformation of
cortical development
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an odds ratio of 0.46 (95% CI = 0.2‐1.0). Details are pre-
sented in Table 3.
3.4 | Risk of bias within studies
None of the 40 eligible studies was free from bias. Details
on risk of bias and applicability assessments for each sub-
group are presented in Appendix S6, Tables S8-S11, and
Figures S3-S6.
3.5 | Risk of bias across studies
Postoperative seizure freedom and improved quality of life
were selected as outcomes of critical importance. Sensitiv-
ity and specificity were categorized as important for deci-
sion making, and were rated as 6 and 4 on a 1‐9 scale,
respectively. Adverse events related to LTM were mainly
classified as critical for decision making.
We defined baseline quality as high. The reasons for
this decision are explained in Appendix S7. After applying
the GRADE criteria, we eventually ended up with a very
low quality of evidence. Rationales for our judgments were
documented and made transparent (Appendix S7). Evidence
tables and the summary of findings tables can be found in
Tables S12-S21.2.
4 | DISCUSSION
This is the first systematic review and meta‐analysis evalu-
ating diagnostic accuracy of noninvasive LTM in the
presurgical evaluation of epilepsy patients. As already men-
tioned in the Materials and Methods section, our approach
was different from the conventional method of assessing
the diagnostic accuracy of a test. This is mainly because
the purpose of noninvasive LTM during presurgical
TABLE 2 Postoperative seizure freedom rates with respect to localizing and nonlocalizing LTM in different subgroups of patients
LTM Site of surgical resection Seizure‐free patients, n (%)a Non–seizure‐free patients, n (%)a
Lesional TLE group
Localizingb LTM Concordant with resection sitec 247 (74) 86 (26)
Discordant with resection site 10 (83) 2 (17)
Nonlocalizingd LTM N/A 41 (67) 20 (33)
Lesional ETLE group
Localizing LTM Concordant with resection site 34 (61) 22 (39)
Discordant with resection site 2 (67) 1 (33)
Nonlocalizing LTM N/A 38 (72) 11 (22)
Nonlesional TLE group
Localizing LTM Concordant with resection site 4 (36) 7 (64)
Discordant with resection site 1 (33) 2 (67)
Nonlocalizing LTM N/A 0 (0) 0 (0)
Nonlesional ETLE group
Localizing LTM Concordant with resection site 2 (50) 2 (50)
Discordant with resection site 0 (0) 0 (0)
Nonlocalizing LTM N/A 1 (50) 1 (50)
ETLE, extratemporal lobe epilepsy; LTM, long‐term video‐electroencephalographic monitoring; N/A, not applicable; TLE, temporal lobe epilepsy.
aPercentage was calculated per each category (eg, rate of seizure‐free patients per “localizing LTM, concordant with resection site” category).
bLTM findings localizing to a single brain area.
cSide and region of surgery.
dLTM findings pointing to more than one separate brain area or to the involvement of an entire brain, or were noninformative.
TABLE 3 Odds ratios representing the odds of being seizure‐free
if the LTM is localizinga and concordant with the surgical resection
compared to nonlocalizingb LTM
Odds ratioc
95% CI
lower
95% CI
upper
Lesional TLE 1.41 0.79 2.53
Lesional ETLE 0.46 0.20 1.07
Nonlesional TLE 0.60 0.01 35.86
Nonlesional ETLE 1.00 0.06 17.51
CI, confidence interval; ETLE, extratemporal lobe epilepsy; LTM, long‐term
video‐electroencephalographic monitoring; TLE, temporal lobe epilepsy.
aLTM findings localizing to a single brain area.
bLTM findings pointing to more than one separate brain area or to the entire
brain, or were noninformative.
cThe cutoff value is 1.
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evaluation is to localize the EZ in patients with a previ-
ously established condition, and therefore it addresses the
localization‐related rather than the diagnostic question. Fur-
thermore, in the case of a standard diagnostic test,
dichotomization of test results into positive or negative
depends on predefined cutoff values; however, this does
not apply to LTM. This explains our choice to classify
LTM findings into localizing and nonlocalizing. Another
important issue to be considered was to precisely define
the degree of overlap between the brain area being local-
ized by LTM and the area resected during epilepsy surgery.
In those cases where LTM pointed to a more extensive
area than was surgically resected, we considered concor-
dance as partial; however, we still classified them as con-
cordant cases. After classifying results as TP, FN, TN, or
FP, we attempted to translate these diagnostic accuracy
measures into sensitivity and specificity. It must be empha-
sized that in the present review neither sensitivity nor
specificity can be interpreted in a straightforward way.
Specifically, sensitivity and specificity did not rely only on
results of LTM (ie, it is not a pure indicator of diagnostic
accuracy), but also on surgery itself. Hence, they reflect
both diagnostic accuracy and prognosis. Furthermore, sen-
sitivity and specificity of LTM can be influenced by the
accuracy of other diagnostic modalities of presurgical
workup, as they also contribute to the surgical decision and
have an impact on postoperative seizure outcome. Consid-
ering that our study includes series from 1993 to 2017, the
diagnostic technologies used in the presurgical workup
might vary across included papers. However, available data
do not allow exploration of the degree of heterogeneity
between those technologies and their impact on the diag-
nostic accuracy of LTM.
Subgroup analysis demonstrated that the sensitivity is
substantially higher in the lesional TLE group compared to
the lesional ETLE group. This finding was also supported
by moderator analyses that pointed to a significant impact
on sensitivity with increasing proportion of patients with
ETLE. These numbers reflect the clinical practice when
LTM is usually nonlocalizing in frontal lobe epilepsy
patients with hypermotor seizures (mainly such patients
comprise the ETLE group). Moreover, our results indicate
that the chance of being seizure‐free is higher when LTM
is localizing; however, substantial variability among studies
indicates that definitive conclusions cannot be drawn. In
summary, our findings are in line with the established sci-
entific evidence showing that scalp EEG recordings are not
sufficient in many instances, such as ETLE or nonlesional
TLE, and further invasive investigations may be
required.24–26 Subgroup analysis demonstrated the low
specificity of LTM in both the lesional TLE and ETLE
groups. Low specificity was determined by a high propor-
tion of FP cases. This would mean that LTM identified
some presumed EZ, but the patient was not seizure‐free
after surgery. Partially, this means that LTM failed in cor-
rectly identifying the EZ. However, the fact that the patients
could not achieve seizure freedom after surgery might also
indicate failure of other diagnostic tests aside from LTM.
We can only speculate that low specificity is determined by
the proportion of “difficult” patients in whom the identifica-
tion of the EZ is extremely challenging.
There are also some other determinants that may influ-
ence diagnostic test performance, including type and con-
duct of LTM, electrode placement systems employed, use
of additional electrodes, duration of LTM, number of sei-
zures recorded, provocative methods used to elicit seizures
in epilepsy monitoring units (eg, withdrawal of antiepileptic
drugs), and qualification of personnel reading the LTM
recordings. Unfortunately, most studies (75/94, 80%) failed
to report the relevant data. Hence, available evidence does
not allow for any conclusions regarding the technical
requirements and procedures of the LTM.
Another major challenge in evaluating the diagnostic
accuracy of LTM is choosing the right reference standard.
Although invasive LTM is considered a gold standard in
the evaluation of patients for epilepsy surgery, not all can-
didates undergo investigations; hence, its applicability is
limited. Another reference standard we sought to adopt for
this review was a consensus decision made at the multidis-
ciplinary epilepsy surgery conference. However, significant
diversities observed in presurgical evaluation of patients
across different epilepsy centers make this challenging.27–29
Furthermore, studies either do not state explicitly, or do not
report at all, the decision‐making pathways used in assess-
ment of eligibility for epilepsy surgery. Therefore, for the
purpose of this review, we decided to choose postoperative
seizure freedom as reference standard. It has been reported
that the success of epilepsy surgery depends on the accu-
rate localization of the EZ, which is defined as the mini-
mum amount of brain tissue responsible for seizure
generation, removal of which may lead to seizure free-
dom.30 Therefore, the ability of LTM to correctly localize
the EZ can be judged based on postoperative seizure out-
come, where localizing LTM results are supported by
achieving seizure freedom at a minimum of 1 year of post-
operative follow‐up. However, this reference standard also
has some limitations that need to be addressed. Because
the EZ is a hypothetical construct generated by results of
different investigations, one can argue that the LTM alone
is not sufficient to define the EZ (location and boundaries).
Therefore, the diagnostic accuracy measures reported in our
review should rather be considered as “diagnostic value of
a multiple‐investigations approach” including LTM. Fur-
thermore, several factors influence postoperative seizure
outcome. These include type of lesion, type of surgery
performed, extent of surgical resection, professional
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qualification of neurosurgeon, and setting where surgery
was conducted. We attempted to minimize this influence
by narrowing the target population for subgroup analysis
down to the individual patient level. Particularly, we
included only those patients who underwent resective sur-
gery with a complete resection of a presumed EZ for phar-
macoresistant focal epilepsy. By doing so, we created a
scenario where achievement of postoperative seizure free-
dom was highly expected. If a patient failed to achieve sei-
zure freedom, this could most likely be attributed to a
limited diagnostic ability of LTM to correctly localize an
EZ.
Several studies have looked at the postoperative seizure
outcome with short (ie, 1‐5 years) and long (ie, >5 years)
of follow‐up, respectively.31–33 Of note, a systematic
review by Tellez‐Zenteno and colleagues34 found that the
long‐term follow‐up after epilepsy surgery is associated
with less favorable seizure outcomes compared to outcomes
observed relatively shortly after epilepsy surgery. In our
study, three different postoperative evaluation scales were
applied and the range of follow‐up evaluation varied from
1.1 to 24.5 years, thus introducing an additional source of
heterogeneity.
That LTM does not stand alone in presurgical evalua-
tion of epilepsy but is part of a diagnostic hierarchy some-
times leads to discordant results between different
investigations, and the decision for conducting surgery may
be based on MRI results or other investigations rather than
LTM. Therefore, it is essential to understand the indepen-
dent contribution of each consecutive diagnostic modality
to the decision‐making process. Unfortunately, currently
available scientific evidence does not allow for such an
assessment.
5 | LIMITATIONS
The main limitations were associated with poor method-
ological quality and poor reporting of included studies
leading to a large between‐study variability/heterogeneity.
We therefore analyzed the subgroups of patients at the
individual patient level. However, due to the small number
of studies, we could not assess the impact of several
covariates simultaneously, but had to stay with separate
univariate analyses. Moreover, a substantial number of
studies, and hence also the respective patients were
excluded due to unavailability of individual patient data.
Especially in studies with moderately large samples, mainly
aggregate data were reported. This could have introduced
additional bias. Unfortunately, due to insufficient data,
diagnostic accuracy could not be assessed in nonlesional
TLE and ETLE groups at all. It is worth mentioning that in
general original studies did not report data on the subset of
patients who underwent noninvasive LTM but for some
reason (eg, not a surgical candidate, refused to undergo
surgery, lost to follow‐up) did not undergo surgery.
Although we acknowledge that these data could not be
used for sensitivity and specificity analysis due to missing
reference standard, it could still be useful for evaluating the
extent to which the accuracy measures could have been
underestimated/overestimated.
6 | CONCLUSIONS
Our systematic review found that the overall pooled esti-
mates of sensitivity and specificity for noninvasive LTM in
identification of EZ are moderate to low. In lesional TLE,
sensitivity is relatively high, whereas specificity is consid-
erably low. In lesional ETLE, both the sensitivity and
specificity are moderate. Furthermore, the diagnostic accu-
racy in lesional TLE patients varies depending on etiology.
However, due to limited, often incomplete, and very
heterogeneous evidence, this aspect requires further investi-
gation.
Our results also indicate that in lesional TLE patients,
the chances of being seizure‐free are larger when LTM is
localizing and concordant with the site of surgical resec-
tion, compared to those patients in whom it is nonlocaliz-
ing. However, again, definitive conclusions cannot be
made.
Considering the issues discussed above, it is obvious
that the evaluation of diagnostic test performance on the
basis of available scientific evidence has major limita-
tions. The majority of the studies that we analyzed did
not directly address the research question of our review.
Therefore, the low quality of the evidence analyzed in
the present study (as shown by QUADAS and GRADE
results) leads to the conclusion that more focused stud-
ies are needed to reliably determine the role of LTM in
epilepsy surgery. This is reflected in difficulties regard-
ing interpretation and subsequent application of test
accuracy measures in clinical practice. There is a clear
need for improvement in planning, conducting, and
reporting of studies on LTM. Moreover, prospective
multicenter studies are necessary to evaluate the added
value of different diagnostic modalities of presurgical
workup, and to enable the standardization of this pro-
cess. To this end, a national outcome registry with stan-
dardized recorded data from European epilepsy centers
is essential. Despite the various substantial limitations,
our study provides an important reference point for
guiding further research and development in this area.
Furthermore, we provide recommendations Appendix S7,
Table S22 on reporting in future studies assessing the
value of LTM in epilepsy surgery.
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